ALBME

Volume 34 Number 3 | 2019

  • 2020 license and registration renewals;
  • Notice - Licensee Portal;
  • Welcome to new employees;
  • ALBME social media guidelines;
  • Starting Nov. 18 Gabapentin will be a Schedule V drug;
  • Administrative rule changes;
  • Public actions of the Board and Commission.

Read Now